Acute leukemias in children with Down syndrome.

Acute leukemias in children with Down syndrome.

अन्य संस्करण दिखाएं (1)

Children with Down syndrome have an increased risk for developing both acute myeloid as well as lymphoblastic leukemia. These leukemias differ in presenting characteristics and underlying biology when compared with leukemias occurring in non-Down syndrome children. Myeloid leukemia in children with...

पूर्ण विवरण

ग्रंथसूची विवरण
मुख्य लेखकों:	Zwaan, M, Reinhardt, D, Hitzler, J, Vyas, P
स्वरूप:	Journal article
भाषा:	English
प्रकाशित:	2008

समान संसाधन

Acute leukemias in children with Down syndrome.
द्वारा: Zwaan, C, और अन्य
प्रकाशित: (2010)

GATA1s induces hyperproliferation of eosinophil precursors in Down syndrome transient leukemia.
द्वारा: Maroz, A, और अन्य
प्रकाशित: (2014)

GATA1s induces hyperproliferation of eosinophil precursors in Down syndrome transient leukemia
द्वारा: Maroz, A, और अन्य
प्रकाशित: (2014)

Acute leukemia in children with Down syndrome
द्वारा: Ana C. Xavier, और अन्य
प्रकाशित: (2010-07-01)

GATA1 Mutation In Transient Leukemia (TL) and Myeloid Leukemia of Down Syndrome
द्वारा: Reinhardt, K, और अन्य
प्रकाशित: (2010)

GATA1 Mutation In Transient Leukemia (TL) and Myeloid Leukemia of Down Syndrome
द्वारा: Reinhardt, K, और अन्य
प्रकाशित: (2010)

Myeloid pre-leukemia and leukemia of Down syndrome
द्वारा: Cruz Hernandez, D, और अन्य
प्रकाशित: (2020)

Down syndrome preleukemia and leukemia.
द्वारा: Maloney, K, और अन्य
प्रकाशित: (2014)

Methotrexate-induced side effects are not due to differences in pharmacokinetics in children with Down syndrome and acute lymphoblastic leukemia
द्वारा: Trudy D. Buitenkamp, और अन्य
प्रकाशित: (2010-07-01)

Molecular insights into Down syndrome-associated leukemia.
द्वारा: Vyas, P, और अन्य
प्रकाशित: (2007)

JAK mutations in Down syndrome - associated transient myeloproliferative disorder and acute megakaryocytic leukemia
द्वारा: Vyas, P, और अन्य
प्रकाशित: (2008)

Myeloid leukemia in children 4 years or older with Down syndrome often lacks GATA1 mutation and cytogenetics and risk of relapse are more akin to sporadic AML.
द्वारा: Hasle, H, और अन्य
प्रकाशित: (2008)

Modelling the progression of a preleukemic stage to overt leukemia in children with down syndrome
द्वारा: Labuhn, M, और अन्य
प्रकाशित: (2018)

Low-dose cytarabine to prevent myeloid leukemia in children with Down syndrome: TMD Prevention 2007 study
द्वारा: Marius Flasinski, और अन्य
प्रकाशित: (2018-07-01)

THE ACUTE LYMPHOBLASTIC LEUKEMIA OF DOWN SYNDROME
द्वारा: Cemile SELIMOGLU, और अन्य
प्रकाशित: (2022-10-01)

Mechanisms of progression of myeloid preleukemia to transformed myeloid leukemia in children with Down syndrome
द्वारा: Labuhn, M, और अन्य
प्रकाशित: (2019)

Analysis of GATA1 mutations in Down syndrome transient myeloproliferative disorder and myeloid leukemia.
द्वारा: Alford, K, और अन्य
प्रकाशित: (2011)

Acute leukemia in children with Down’s syndrome: the importance of population based study
द्वारा: Rebecca James, और अन्य
प्रकाशित: (2008-08-01)

Epigenome-wide association study of acute lymphoblastic leukemia in children with Down syndrome
द्वारा: Li, S, और अन्य
प्रकाशित: (2022)

Germline variants in predisposition genes in children with Down syndrome and acute lymphoblastic leukemia
द्वारा: Winer, P, और अन्य
प्रकाशित: (2020)

Outcome in children with Down's syndrome and acute lymphoblastic leukemia: role of IKZF1 deletions and CRLF2 aberrations.
द्वारा: Buitenkamp, T, और अन्य
प्रकाशित: (2012)

Outcome in children with Down's syndrome and acute lymphoblastic leukemia: role of IKZF1 deletions and CRLF2 aberrations
द्वारा: Buitenkamp, T, और अन्य
प्रकाशित: (2012)

Treatment of acute lymphocytic leukemia in Down syndrome
द्वारा: Yuki Gemma, और अन्य
प्रकाशित: (2017-01-01)

BTG1 deletions do not predict outcome in Down syndrome acute lymphoblastic leukemia.
द्वारा: Buitenkamp, T, और अन्य
प्रकाशित: (2013)

BTG1 deletions do not predict outcome in Down syndrome acute lymphoblastic leukemia
द्वारा: Buitenkamp, T, और अन्य
प्रकाशित: (2013)

Analysis of JAK3, JAK2, and C-MPL mutations in transient myeloproliferative disorder and myeloid leukemia of Down syndrome blasts in children with Down syndrome.
द्वारा: Norton, A, और अन्य
प्रकाशित: (2007)

Down syndrome and leukemia: from basic mechanisms to clinical advances
द्वारा: André Baruchel, और अन्य
प्रकाशित: (2023-07-01)

Haematology of Down syndrome.
द्वारा: Webb, D, और अन्य
प्रकाशित: (2007)

Features of acute megakaryoblastic leukemia diagnosis in a child with Down syndrome
द्वारा: N. K. Guskova, और अन्य
प्रकाशित: (2023-03-01)

Sensitive, rapid diagnostic test for transient abnormal myelopoiesis and myeloid leukemia of Down syndrome
द्वारा: Cruz Hernandez, D, और अन्य
प्रकाशित: (2020)

Gemtuzumab ozogamicin in acute myeloid leukemia: act 2, with perhaps more to come
द्वारा: Johann Hitzler, और अन्य
प्रकाशित: (2019-01-01)

Biology and management of transient abnormal myelopoiesis (TAM) in children with Down syndrome.
द्वारा: Roy, A, और अन्य
प्रकाशित: (2012)

Acute megakaryoblastic leukaemia in Down syndrome and non-Down syndrome patients - molecular signature of a disease - subtypes with distinct treatment outcomes
द्वारा: Vyas, P, और अन्य
प्रकाशित: (2007)

Acute Kidney Injury in Myeloid Leukemia of Down Syndrome: Risk Factors and Outcomes
द्वारा: Chompoonut Limratchapong, और अन्य
प्रकाशित: (2023-03-01)

Molecular Mechanisms of the Genetic Predisposition to Acute Megakaryoblastic Leukemia in Infants With Down Syndrome
द्वारा: Juliane Grimm, और अन्य
प्रकाशित: (2021-03-01)

Mosaic Down syndrome and acute lymphoblastic B cell-leukemia. Case report
द्वारा: Parra-Baltazar, Isabel Mónica, और अन्य
प्रकाशित: (2016-10-01)

Down syndrome-like acute megakaryoblastic leukemia in a patient with Cornelia de Lange syndrome
द्वारा: Yoann Vial, और अन्य
प्रकाशित: (2018-06-01)

Efficacy of DYRK1A inhibitors in novel models of Down syndrome acute lymphoblastic leukemia
द्वारा: Shannon L. Carey-Smith, और अन्य
प्रकाशित: (2024-02-01)

GATA1 mutation analysis demonstrates two distinct primary leukemias in a child with down syndrome; implications for leukemogenesis.
द्वारा: Hellebostad, M, और अन्य
प्रकाशित: (2005)

Frequency of cardiovascular and gastrointestinal malformations, leukemia and hypothyroidism in children with Down syndrome in Trabzon, Turkey
द्वारा: F M Aynaci, और अन्य
प्रकाशित: (1998-01-01)